![]() Aspira Women's Health Vermillion develops and commercializesdiagnostic teststhat address unmet needs in gynecologic oncology and womens health. | ||
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Austin, US HQ | Locations HQ |
Employees | Employees 4310% increase | Employees N/A |

Prosigna is a test for breast cancer developed by Veracyte to measure recurrence risk.
View company